May/June 2018
Biopharma Asia
May/June 2018 | Volume 7 Issue 3
Launching a Biological Drug in China: From Biosimilar to Innovative Molecules Key Consider...
Joe X Zhou, Ph.D., CEO Genor BioPharma Jinhai Shi, Ph.D., General Secretary China Protei...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Principal Scientist Janssen R&D
Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Co...
Thorsten Lorenz, PhD, Head Developability Assessment Thomas Jostock, PhD, Science and Te...
Raw Material Qualification – A Practical Approach
Aurora Henry, Biopharmaceutical Professional CMC Biologics
Keys to Successful Implementation of Single-Use Technology
How and why collaboration improves single-use products Willem Kools, PhD., Head of Technol...
How To Select The Right Filter Integrity Test Instrument
Pall Biotech
















